nodes	percent_of_prediction	percent_of_DWPC	metapath
Nelarabine—Nucleic Acid Synthesis Inhibitors—Azathioprine—multiple sclerosis	0.309	1	CiPCiCtD
Nelarabine—Cladribine—multiple sclerosis	0.282	1	CrCtD
Nelarabine—POLA1—Cladribine—multiple sclerosis	0.101	0.619	CbGbCtD
Nelarabine—Abacavir—Cladribine—multiple sclerosis	0.0745	0.376	CrCrCtD
Nelarabine—DCK—Cladribine—multiple sclerosis	0.0625	0.381	CbGbCtD
Nelarabine—Clofarabine—Cladribine—multiple sclerosis	0.0178	0.0896	CrCrCtD
Nelarabine—Regadenoson—Cladribine—multiple sclerosis	0.0178	0.0896	CrCrCtD
Nelarabine—Fludarabine—Cladribine—multiple sclerosis	0.0167	0.0841	CrCrCtD
Nelarabine—Adenosine monophosphate—Cladribine—multiple sclerosis	0.0157	0.0792	CrCrCtD
Nelarabine—Adenosine—Cladribine—multiple sclerosis	0.0141	0.0712	CrCrCtD
Nelarabine—Vidarabine—Cladribine—multiple sclerosis	0.0141	0.0712	CrCrCtD
Nelarabine—Azacitidine—Cladribine—multiple sclerosis	0.0141	0.0712	CrCrCtD
Nelarabine—Decitabine—Cladribine—multiple sclerosis	0.0134	0.0678	CrCrCtD
Nelarabine—DGUOK—retina—multiple sclerosis	0.000917	0.112	CbGeAlD
Nelarabine—S-Adenosylmethionine—SRM—multiple sclerosis	0.000711	0.479	CrCbGaD
Nelarabine—DGUOK—medulla oblongata—multiple sclerosis	0.000663	0.0806	CbGeAlD
Nelarabine—DGUOK—midbrain—multiple sclerosis	0.000606	0.0737	CbGeAlD
Nelarabine—DGUOK—spinal cord—multiple sclerosis	0.000591	0.0719	CbGeAlD
Nelarabine—POLA1—retina—multiple sclerosis	0.000566	0.0688	CbGeAlD
Nelarabine—DGUOK—nervous system—multiple sclerosis	0.000498	0.0606	CbGeAlD
Nelarabine—DGUOK—central nervous system—multiple sclerosis	0.00048	0.0583	CbGeAlD
Nelarabine—DGUOK—cerebellum—multiple sclerosis	0.000469	0.057	CbGeAlD
Nelarabine—POLA1—Nucleotide Metabolism—SRM—multiple sclerosis	0.000432	0.174	CbGpPWpGaD
Nelarabine—DGUOK—brain—multiple sclerosis	0.000381	0.0463	CbGeAlD
Nelarabine—DCK—retina—multiple sclerosis	0.000349	0.0424	CbGeAlD
Nelarabine—DGUOK—Nucleotide metabolism—RRM1—multiple sclerosis	0.000332	0.134	CbGpPWpGaD
Nelarabine—Clofarabine—RRM1—multiple sclerosis	0.000304	0.205	CrCbGaD
Nelarabine—Fludarabine—RRM1—multiple sclerosis	0.000295	0.199	CrCbGaD
Nelarabine—POLA1—cerebellum—multiple sclerosis	0.000289	0.0352	CbGeAlD
Nelarabine—ADA—nervous system—multiple sclerosis	0.000285	0.0347	CbGeAlD
Nelarabine—ADA—central nervous system—multiple sclerosis	0.000274	0.0334	CbGeAlD
Nelarabine—DCK—medulla oblongata—multiple sclerosis	0.000252	0.0307	CbGeAlD
Nelarabine—POLA1—brain—multiple sclerosis	0.000235	0.0286	CbGeAlD
Nelarabine—POLA1—Nucleotide Metabolism—RRM1—multiple sclerosis	0.00023	0.0928	CbGpPWpGaD
Nelarabine—DCK—midbrain—multiple sclerosis	0.00023	0.028	CbGeAlD
Nelarabine—DCK—spinal cord—multiple sclerosis	0.000225	0.0273	CbGeAlD
Nelarabine—ADA—brain—multiple sclerosis	0.000218	0.0265	CbGeAlD
Nelarabine—DCK—nervous system—multiple sclerosis	0.000189	0.023	CbGeAlD
Nelarabine—DCK—central nervous system—multiple sclerosis	0.000182	0.0222	CbGeAlD
Nelarabine—DCK—cerebellum—multiple sclerosis	0.000178	0.0217	CbGeAlD
Nelarabine—Cladribine—RRM1—multiple sclerosis	0.000175	0.118	CrCbGaD
Nelarabine—DCK—brain—multiple sclerosis	0.000145	0.0176	CbGeAlD
Nelarabine—ADA—p73 transcription factor network—IL4R—multiple sclerosis	0.000117	0.0473	CbGpPWpGaD
Nelarabine—ADA—Nucleotide metabolism—RRM1—multiple sclerosis	0.00011	0.0444	CbGpPWpGaD
Nelarabine—DCK—Nucleotide metabolism—RRM1—multiple sclerosis	0.000102	0.041	CbGpPWpGaD
Nelarabine—DCK—Retinoblastoma (RB) in Cancer—RRM1—multiple sclerosis	9.32e-05	0.0376	CbGpPWpGaD
Nelarabine—POLA1—E2F transcription factor network—RRM1—multiple sclerosis	7.85e-05	0.0316	CbGpPWpGaD
Nelarabine—ADA—Validated transcriptional targets of deltaNp63 isoforms—VDR—multiple sclerosis	7.14e-05	0.0288	CbGpPWpGaD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—RRM1—multiple sclerosis	6.82e-05	0.0275	CbGpPWpGaD
Nelarabine—DCK—Desoximetasone—Methylprednisolone—multiple sclerosis	6.67e-05	0.0885	CbGdCrCtD
Nelarabine—DCK—Desoximetasone—Betamethasone—multiple sclerosis	6.56e-05	0.0871	CbGdCrCtD
Nelarabine—DCK—Desoximetasone—Dexamethasone—multiple sclerosis	6.56e-05	0.0871	CbGdCrCtD
Nelarabine—DCK—Diflorasone—Methylprednisolone—multiple sclerosis	6.47e-05	0.0859	CbGdCrCtD
Nelarabine—DCK—Desoximetasone—Triamcinolone—multiple sclerosis	6.41e-05	0.0851	CbGdCrCtD
Nelarabine—ADA—Validated transcriptional targets of TAp63 isoforms—VDR—multiple sclerosis	6.39e-05	0.0257	CbGpPWpGaD
Nelarabine—DCK—Diflorasone—Betamethasone—multiple sclerosis	6.37e-05	0.0846	CbGdCrCtD
Nelarabine—DCK—Diflorasone—Dexamethasone—multiple sclerosis	6.37e-05	0.0846	CbGdCrCtD
Nelarabine—DCK—Diflorasone—Triamcinolone—multiple sclerosis	6.23e-05	0.0826	CbGdCrCtD
Nelarabine—DCK—Desoximetasone—Prednisone—multiple sclerosis	6.09e-05	0.0808	CbGdCrCtD
Nelarabine—DCK—Desoximetasone—Prednisolone—multiple sclerosis	5.94e-05	0.0789	CbGdCrCtD
Nelarabine—DCK—Diflorasone—Prednisone—multiple sclerosis	5.91e-05	0.0784	CbGdCrCtD
Nelarabine—DCK—Diflorasone—Prednisolone—multiple sclerosis	5.77e-05	0.0765	CbGdCrCtD
Nelarabine—DGUOK—Metabolism—SRM—multiple sclerosis	5.65e-05	0.0228	CbGpPWpGaD
Nelarabine—ADA—Validated transcriptional targets of TAp63 isoforms—FAS—multiple sclerosis	5.57e-05	0.0224	CbGpPWpGaD
Nelarabine—ADA—p73 transcription factor network—FAS—multiple sclerosis	4.11e-05	0.0165	CbGpPWpGaD
Nelarabine—Convulsion—Mitoxantrone—multiple sclerosis	4.09e-05	0.00122	CcSEcCtD
Nelarabine—Abdominal distension—Prednisone—multiple sclerosis	4.07e-05	0.00121	CcSEcCtD
Nelarabine—Neuropathy peripheral—Betamethasone—multiple sclerosis	4.05e-05	0.00121	CcSEcCtD
Nelarabine—Neuropathy peripheral—Dexamethasone—multiple sclerosis	4.05e-05	0.00121	CcSEcCtD
Nelarabine—Arthralgia—Mitoxantrone—multiple sclerosis	4.02e-05	0.0012	CcSEcCtD
Nelarabine—Chest pain—Mitoxantrone—multiple sclerosis	4.02e-05	0.0012	CcSEcCtD
Nelarabine—Myalgia—Mitoxantrone—multiple sclerosis	4.02e-05	0.0012	CcSEcCtD
Nelarabine—Connective tissue disorder—Methylprednisolone—multiple sclerosis	4.01e-05	0.0012	CcSEcCtD
Nelarabine—Diarrhoea—Cladribine—multiple sclerosis	4.01e-05	0.0012	CcSEcCtD
Nelarabine—Lethargy—Methotrexate—multiple sclerosis	3.99e-05	0.00119	CcSEcCtD
Nelarabine—DGUOK—Metabolism—CYP24A1—multiple sclerosis	3.98e-05	0.016	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—CYP27B1—multiple sclerosis	3.98e-05	0.016	CbGpPWpGaD
Nelarabine—Feeling abnormal—Azathioprine—multiple sclerosis	3.93e-05	0.00117	CcSEcCtD
Nelarabine—Osteoarthritis—Methotrexate—multiple sclerosis	3.91e-05	0.00117	CcSEcCtD
Nelarabine—Gastrointestinal pain—Azathioprine—multiple sclerosis	3.9e-05	0.00116	CcSEcCtD
Nelarabine—Confusional state—Mitoxantrone—multiple sclerosis	3.88e-05	0.00116	CcSEcCtD
Nelarabine—Dizziness—Cladribine—multiple sclerosis	3.88e-05	0.00116	CcSEcCtD
Nelarabine—Oedema—Mitoxantrone—multiple sclerosis	3.85e-05	0.00115	CcSEcCtD
Nelarabine—Infection—Mitoxantrone—multiple sclerosis	3.83e-05	0.00114	CcSEcCtD
Nelarabine—Eye disorder—Methylprednisolone—multiple sclerosis	3.81e-05	0.00114	CcSEcCtD
Nelarabine—Cardiac disorder—Methylprednisolone—multiple sclerosis	3.79e-05	0.00113	CcSEcCtD
Nelarabine—Neutropenia—Prednisone—multiple sclerosis	3.78e-05	0.00113	CcSEcCtD
Nelarabine—Thrombocytopenia—Mitoxantrone—multiple sclerosis	3.77e-05	0.00113	CcSEcCtD
Nelarabine—Abdominal pain—Azathioprine—multiple sclerosis	3.77e-05	0.00112	CcSEcCtD
Nelarabine—Body temperature increased—Azathioprine—multiple sclerosis	3.77e-05	0.00112	CcSEcCtD
Nelarabine—Vomiting—Cladribine—multiple sclerosis	3.73e-05	0.00111	CcSEcCtD
Nelarabine—Angiopathy—Methylprednisolone—multiple sclerosis	3.7e-05	0.00111	CcSEcCtD
Nelarabine—Mediastinal disorder—Methylprednisolone—multiple sclerosis	3.68e-05	0.0011	CcSEcCtD
Nelarabine—Anorexia—Mitoxantrone—multiple sclerosis	3.67e-05	0.0011	CcSEcCtD
Nelarabine—Ataxia—Methotrexate—multiple sclerosis	3.67e-05	0.0011	CcSEcCtD
Nelarabine—Headache—Cladribine—multiple sclerosis	3.67e-05	0.0011	CcSEcCtD
Nelarabine—Vision blurred—Prednisolone—multiple sclerosis	3.65e-05	0.00109	CcSEcCtD
Nelarabine—Hyperglycaemia—Prednisone—multiple sclerosis	3.64e-05	0.00109	CcSEcCtD
Nelarabine—DGUOK—Metabolism—GPC5—multiple sclerosis	3.64e-05	0.0147	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	3.64e-05	0.0147	CbGpPWpGaD
Nelarabine—Hypotension—Mitoxantrone—multiple sclerosis	3.6e-05	0.00107	CcSEcCtD
Nelarabine—Depression—Prednisone—multiple sclerosis	3.59e-05	0.00107	CcSEcCtD
Nelarabine—Mental disorder—Methylprednisolone—multiple sclerosis	3.58e-05	0.00107	CcSEcCtD
Nelarabine—Malnutrition—Methylprednisolone—multiple sclerosis	3.55e-05	0.00106	CcSEcCtD
Nelarabine—Neuropathy peripheral—Prednisone—multiple sclerosis	3.53e-05	0.00105	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	3.51e-05	0.00105	CcSEcCtD
Nelarabine—Dysgeusia—Triamcinolone—multiple sclerosis	3.49e-05	0.00104	CcSEcCtD
Nelarabine—Nausea—Cladribine—multiple sclerosis	3.48e-05	0.00104	CcSEcCtD
Nelarabine—Eye disorder—Betamethasone—multiple sclerosis	3.47e-05	0.00104	CcSEcCtD
Nelarabine—Eye disorder—Dexamethasone—multiple sclerosis	3.47e-05	0.00104	CcSEcCtD
Nelarabine—Paraesthesia—Mitoxantrone—multiple sclerosis	3.46e-05	0.00103	CcSEcCtD
Nelarabine—Back pain—Triamcinolone—multiple sclerosis	3.44e-05	0.00103	CcSEcCtD
Nelarabine—Dyspnoea—Mitoxantrone—multiple sclerosis	3.43e-05	0.00103	CcSEcCtD
Nelarabine—Somnolence—Mitoxantrone—multiple sclerosis	3.42e-05	0.00102	CcSEcCtD
Nelarabine—Loss of consciousness—Prednisolone—multiple sclerosis	3.4e-05	0.00102	CcSEcCtD
Nelarabine—Angiopathy—Betamethasone—multiple sclerosis	3.37e-05	0.00101	CcSEcCtD
Nelarabine—Angiopathy—Dexamethasone—multiple sclerosis	3.37e-05	0.00101	CcSEcCtD
Nelarabine—Convulsion—Prednisolone—multiple sclerosis	3.36e-05	0.001	CcSEcCtD
Nelarabine—Decreased appetite—Mitoxantrone—multiple sclerosis	3.35e-05	0.001	CcSEcCtD
Nelarabine—Fatigue—Mitoxantrone—multiple sclerosis	3.32e-05	0.000992	CcSEcCtD
Nelarabine—Pain—Mitoxantrone—multiple sclerosis	3.29e-05	0.000984	CcSEcCtD
Nelarabine—Constipation—Mitoxantrone—multiple sclerosis	3.29e-05	0.000984	CcSEcCtD
Nelarabine—Diarrhoea—Azathioprine—multiple sclerosis	3.26e-05	0.000973	CcSEcCtD
Nelarabine—Connective tissue disorder—Prednisone—multiple sclerosis	3.18e-05	0.000948	CcSEcCtD
Nelarabine—Feeling abnormal—Mitoxantrone—multiple sclerosis	3.17e-05	0.000948	CcSEcCtD
Nelarabine—Oedema—Prednisolone—multiple sclerosis	3.16e-05	0.000944	CcSEcCtD
Nelarabine—Neutropenia—Methotrexate—multiple sclerosis	3.16e-05	0.000942	CcSEcCtD
Nelarabine—Dizziness—Azathioprine—multiple sclerosis	3.15e-05	0.000941	CcSEcCtD
Nelarabine—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	3.15e-05	0.000941	CcSEcCtD
Nelarabine—Loss of consciousness—Triamcinolone—multiple sclerosis	3.13e-05	0.000935	CcSEcCtD
Nelarabine—Loss of consciousness—Methylprednisolone—multiple sclerosis	3.12e-05	0.000932	CcSEcCtD
Nelarabine—Cough—Triamcinolone—multiple sclerosis	3.11e-05	0.000928	CcSEcCtD
Nelarabine—Convulsion—Triamcinolone—multiple sclerosis	3.09e-05	0.000921	CcSEcCtD
Nelarabine—Convulsion—Methylprednisolone—multiple sclerosis	3.08e-05	0.000919	CcSEcCtD
Nelarabine—Abdominal pain—Mitoxantrone—multiple sclerosis	3.05e-05	0.000909	CcSEcCtD
Nelarabine—Body temperature increased—Mitoxantrone—multiple sclerosis	3.05e-05	0.000909	CcSEcCtD
Nelarabine—Myalgia—Triamcinolone—multiple sclerosis	3.03e-05	0.000905	CcSEcCtD
Nelarabine—Vomiting—Azathioprine—multiple sclerosis	3.03e-05	0.000905	CcSEcCtD
Nelarabine—Pneumonia—Methotrexate—multiple sclerosis	3.03e-05	0.000904	CcSEcCtD
Nelarabine—Arthralgia—Methylprednisolone—multiple sclerosis	3.03e-05	0.000903	CcSEcCtD
Nelarabine—Myalgia—Methylprednisolone—multiple sclerosis	3.03e-05	0.000903	CcSEcCtD
Nelarabine—Eye disorder—Prednisone—multiple sclerosis	3.02e-05	0.000902	CcSEcCtD
Nelarabine—DGUOK—Metabolism—RRM1—multiple sclerosis	3.02e-05	0.0122	CbGpPWpGaD
Nelarabine—Infestation NOS—Methotrexate—multiple sclerosis	3.01e-05	0.000899	CcSEcCtD
Nelarabine—Infestation—Methotrexate—multiple sclerosis	3.01e-05	0.000899	CcSEcCtD
Nelarabine—Depression—Methotrexate—multiple sclerosis	3e-05	0.000896	CcSEcCtD
Nelarabine—Headache—Azathioprine—multiple sclerosis	2.99e-05	0.000891	CcSEcCtD
Nelarabine—Stomatitis—Methotrexate—multiple sclerosis	2.93e-05	0.000876	CcSEcCtD
Nelarabine—Angiopathy—Prednisone—multiple sclerosis	2.93e-05	0.000876	CcSEcCtD
Nelarabine—Confusional state—Methylprednisolone—multiple sclerosis	2.92e-05	0.000873	CcSEcCtD
Nelarabine—Oedema—Triamcinolone—multiple sclerosis	2.91e-05	0.000868	CcSEcCtD
Nelarabine—Infection—Triamcinolone—multiple sclerosis	2.89e-05	0.000862	CcSEcCtD
Nelarabine—Infection—Methylprednisolone—multiple sclerosis	2.88e-05	0.00086	CcSEcCtD
Nelarabine—Insomnia—Prednisolone—multiple sclerosis	2.86e-05	0.000853	CcSEcCtD
Nelarabine—Hepatobiliary disease—Methotrexate—multiple sclerosis	2.85e-05	0.00085	CcSEcCtD
Nelarabine—Nervous system disorder—Methylprednisolone—multiple sclerosis	2.84e-05	0.000849	CcSEcCtD
Nelarabine—Loss of consciousness—Dexamethasone—multiple sclerosis	2.84e-05	0.000848	CcSEcCtD
Nelarabine—Loss of consciousness—Betamethasone—multiple sclerosis	2.84e-05	0.000848	CcSEcCtD
Nelarabine—Epistaxis—Methotrexate—multiple sclerosis	2.84e-05	0.000847	CcSEcCtD
Nelarabine—Paraesthesia—Prednisolone—multiple sclerosis	2.84e-05	0.000847	CcSEcCtD
Nelarabine—Mental disorder—Prednisone—multiple sclerosis	2.83e-05	0.000846	CcSEcCtD
Nelarabine—Nausea—Azathioprine—multiple sclerosis	2.83e-05	0.000845	CcSEcCtD
Nelarabine—Malnutrition—Prednisone—multiple sclerosis	2.81e-05	0.00084	CcSEcCtD
Nelarabine—Convulsion—Dexamethasone—multiple sclerosis	2.8e-05	0.000836	CcSEcCtD
Nelarabine—Convulsion—Betamethasone—multiple sclerosis	2.8e-05	0.000836	CcSEcCtD
Nelarabine—Asthenia—Mitoxantrone—multiple sclerosis	2.76e-05	0.000825	CcSEcCtD
Nelarabine—Myalgia—Dexamethasone—multiple sclerosis	2.75e-05	0.000821	CcSEcCtD
Nelarabine—Myalgia—Betamethasone—multiple sclerosis	2.75e-05	0.000821	CcSEcCtD
Nelarabine—Hypotension—Methylprednisolone—multiple sclerosis	2.71e-05	0.000809	CcSEcCtD
Nelarabine—Pain—Prednisolone—multiple sclerosis	2.7e-05	0.000807	CcSEcCtD
Nelarabine—Urinary tract disorder—Methotrexate—multiple sclerosis	2.67e-05	0.000797	CcSEcCtD
Nelarabine—Vision blurred—Prednisone—multiple sclerosis	2.65e-05	0.000792	CcSEcCtD
Nelarabine—Urethral disorder—Methotrexate—multiple sclerosis	2.65e-05	0.000791	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	2.65e-05	0.000791	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	2.64e-05	0.000789	CcSEcCtD
Nelarabine—Oedema—Betamethasone—multiple sclerosis	2.64e-05	0.000787	CcSEcCtD
Nelarabine—Oedema—Dexamethasone—multiple sclerosis	2.64e-05	0.000787	CcSEcCtD
Nelarabine—Diarrhoea—Mitoxantrone—multiple sclerosis	2.64e-05	0.000787	CcSEcCtD
Nelarabine—Insomnia—Triamcinolone—multiple sclerosis	2.63e-05	0.000785	CcSEcCtD
Nelarabine—Insomnia—Methylprednisolone—multiple sclerosis	2.62e-05	0.000783	CcSEcCtD
Nelarabine—Infection—Betamethasone—multiple sclerosis	2.62e-05	0.000782	CcSEcCtD
Nelarabine—Infection—Dexamethasone—multiple sclerosis	2.62e-05	0.000782	CcSEcCtD
Nelarabine—Paraesthesia—Triamcinolone—multiple sclerosis	2.61e-05	0.000779	CcSEcCtD
Nelarabine—Feeling abnormal—Prednisolone—multiple sclerosis	2.6e-05	0.000778	CcSEcCtD
Nelarabine—Paraesthesia—Methylprednisolone—multiple sclerosis	2.6e-05	0.000777	CcSEcCtD
Nelarabine—Anaemia—Prednisone—multiple sclerosis	2.6e-05	0.000777	CcSEcCtD
Nelarabine—Dyspnoea—Triamcinolone—multiple sclerosis	2.59e-05	0.000774	CcSEcCtD
Nelarabine—Nervous system disorder—Betamethasone—multiple sclerosis	2.59e-05	0.000772	CcSEcCtD
Nelarabine—Nervous system disorder—Dexamethasone—multiple sclerosis	2.59e-05	0.000772	CcSEcCtD
Nelarabine—Thrombocytopenia—Dexamethasone—multiple sclerosis	2.58e-05	0.000771	CcSEcCtD
Nelarabine—Thrombocytopenia—Betamethasone—multiple sclerosis	2.58e-05	0.000771	CcSEcCtD
Nelarabine—Eye disorder—Methotrexate—multiple sclerosis	2.52e-05	0.000754	CcSEcCtD
Nelarabine—Anorexia—Dexamethasone—multiple sclerosis	2.51e-05	0.000751	CcSEcCtD
Nelarabine—Anorexia—Betamethasone—multiple sclerosis	2.51e-05	0.000751	CcSEcCtD
Nelarabine—Cardiac disorder—Methotrexate—multiple sclerosis	2.51e-05	0.000749	CcSEcCtD
Nelarabine—Fatigue—Triamcinolone—multiple sclerosis	2.51e-05	0.000748	CcSEcCtD
Nelarabine—Fatigue—Methylprednisolone—multiple sclerosis	2.5e-05	0.000746	CcSEcCtD
Nelarabine—Pain—Triamcinolone—multiple sclerosis	2.49e-05	0.000742	CcSEcCtD
Nelarabine—ADA—C-MYB transcription factor network—CD4—multiple sclerosis	2.48e-05	0.00998	CbGpPWpGaD
Nelarabine—Loss of consciousness—Prednisone—multiple sclerosis	2.47e-05	0.000738	CcSEcCtD
Nelarabine—Hypotension—Dexamethasone—multiple sclerosis	2.46e-05	0.000736	CcSEcCtD
Nelarabine—Hypotension—Betamethasone—multiple sclerosis	2.46e-05	0.000736	CcSEcCtD
Nelarabine—Angiopathy—Methotrexate—multiple sclerosis	2.45e-05	0.000732	CcSEcCtD
Nelarabine—Vomiting—Mitoxantrone—multiple sclerosis	2.45e-05	0.000731	CcSEcCtD
Nelarabine—Convulsion—Prednisone—multiple sclerosis	2.44e-05	0.000728	CcSEcCtD
Nelarabine—Mediastinal disorder—Methotrexate—multiple sclerosis	2.43e-05	0.000727	CcSEcCtD
Nelarabine—Chills—Methotrexate—multiple sclerosis	2.42e-05	0.000724	CcSEcCtD
Nelarabine—Headache—Mitoxantrone—multiple sclerosis	2.41e-05	0.000721	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	2.4e-05	0.000717	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	2.4e-05	0.000717	CcSEcCtD
Nelarabine—Arthralgia—Prednisone—multiple sclerosis	2.4e-05	0.000715	CcSEcCtD
Nelarabine—Myalgia—Prednisone—multiple sclerosis	2.4e-05	0.000715	CcSEcCtD
Nelarabine—Feeling abnormal—Triamcinolone—multiple sclerosis	2.4e-05	0.000715	CcSEcCtD
Nelarabine—Feeling abnormal—Methylprednisolone—multiple sclerosis	2.39e-05	0.000714	CcSEcCtD
Nelarabine—Insomnia—Dexamethasone—multiple sclerosis	2.39e-05	0.000712	CcSEcCtD
Nelarabine—Insomnia—Betamethasone—multiple sclerosis	2.39e-05	0.000712	CcSEcCtD
Nelarabine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	2.37e-05	0.000708	CcSEcCtD
Nelarabine—Paraesthesia—Dexamethasone—multiple sclerosis	2.37e-05	0.000707	CcSEcCtD
Nelarabine—Paraesthesia—Betamethasone—multiple sclerosis	2.37e-05	0.000707	CcSEcCtD
Nelarabine—Mental disorder—Methotrexate—multiple sclerosis	2.37e-05	0.000707	CcSEcCtD
Nelarabine—Malnutrition—Methotrexate—multiple sclerosis	2.35e-05	0.000702	CcSEcCtD
Nelarabine—Dysgeusia—Methotrexate—multiple sclerosis	2.3e-05	0.000688	CcSEcCtD
Nelarabine—Body temperature increased—Triamcinolone—multiple sclerosis	2.3e-05	0.000686	CcSEcCtD
Nelarabine—Oedema—Prednisone—multiple sclerosis	2.3e-05	0.000686	CcSEcCtD
Nelarabine—Abdominal pain—Methylprednisolone—multiple sclerosis	2.29e-05	0.000684	CcSEcCtD
Nelarabine—Decreased appetite—Dexamethasone—multiple sclerosis	2.29e-05	0.000684	CcSEcCtD
Nelarabine—Decreased appetite—Betamethasone—multiple sclerosis	2.29e-05	0.000684	CcSEcCtD
Nelarabine—Nausea—Mitoxantrone—multiple sclerosis	2.29e-05	0.000683	CcSEcCtD
Nelarabine—Infection—Prednisone—multiple sclerosis	2.28e-05	0.000681	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	2.28e-05	0.00068	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	2.28e-05	0.00068	CcSEcCtD
Nelarabine—Back pain—Methotrexate—multiple sclerosis	2.27e-05	0.000679	CcSEcCtD
Nelarabine—Fatigue—Betamethasone—multiple sclerosis	2.27e-05	0.000679	CcSEcCtD
Nelarabine—Fatigue—Dexamethasone—multiple sclerosis	2.27e-05	0.000679	CcSEcCtD
Nelarabine—Pain—Dexamethasone—multiple sclerosis	2.26e-05	0.000673	CcSEcCtD
Nelarabine—Pain—Betamethasone—multiple sclerosis	2.26e-05	0.000673	CcSEcCtD
Nelarabine—Nervous system disorder—Prednisone—multiple sclerosis	2.25e-05	0.000672	CcSEcCtD
Nelarabine—Vision blurred—Methotrexate—multiple sclerosis	2.22e-05	0.000662	CcSEcCtD
Nelarabine—Anorexia—Prednisone—multiple sclerosis	2.19e-05	0.000654	CcSEcCtD
Nelarabine—Anaemia—Methotrexate—multiple sclerosis	2.17e-05	0.000649	CcSEcCtD
Nelarabine—Feeling abnormal—Betamethasone—multiple sclerosis	2.17e-05	0.000649	CcSEcCtD
Nelarabine—Feeling abnormal—Dexamethasone—multiple sclerosis	2.17e-05	0.000649	CcSEcCtD
Nelarabine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	2.16e-05	0.000644	CcSEcCtD
Nelarabine—Gastrointestinal pain—Betamethasone—multiple sclerosis	2.16e-05	0.000644	CcSEcCtD
Nelarabine—Leukopenia—Methotrexate—multiple sclerosis	2.11e-05	0.000629	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Prednisone—multiple sclerosis	2.09e-05	0.000625	CcSEcCtD
Nelarabine—Dizziness—Prednisolone—multiple sclerosis	2.09e-05	0.000624	CcSEcCtD
Nelarabine—Asthenia—Triamcinolone—multiple sclerosis	2.09e-05	0.000623	CcSEcCtD
Nelarabine—Body temperature increased—Betamethasone—multiple sclerosis	2.08e-05	0.000622	CcSEcCtD
Nelarabine—Abdominal pain—Dexamethasone—multiple sclerosis	2.08e-05	0.000622	CcSEcCtD
Nelarabine—Body temperature increased—Dexamethasone—multiple sclerosis	2.08e-05	0.000622	CcSEcCtD
Nelarabine—Abdominal pain—Betamethasone—multiple sclerosis	2.08e-05	0.000622	CcSEcCtD
Nelarabine—Asthenia—Methylprednisolone—multiple sclerosis	2.08e-05	0.000621	CcSEcCtD
Nelarabine—Insomnia—Prednisone—multiple sclerosis	2.08e-05	0.00062	CcSEcCtD
Nelarabine—Paraesthesia—Prednisone—multiple sclerosis	2.06e-05	0.000616	CcSEcCtD
Nelarabine—Cough—Methotrexate—multiple sclerosis	2.05e-05	0.000613	CcSEcCtD
Nelarabine—Convulsion—Methotrexate—multiple sclerosis	2.04e-05	0.000608	CcSEcCtD
Nelarabine—Chest pain—Methotrexate—multiple sclerosis	2e-05	0.000598	CcSEcCtD
Nelarabine—Arthralgia—Methotrexate—multiple sclerosis	2e-05	0.000598	CcSEcCtD
Nelarabine—Myalgia—Methotrexate—multiple sclerosis	2e-05	0.000598	CcSEcCtD
Nelarabine—Decreased appetite—Prednisone—multiple sclerosis	2e-05	0.000596	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	1.99e-05	0.00803	CbGpPWpGaD
Nelarabine—Diarrhoea—Methylprednisolone—multiple sclerosis	1.98e-05	0.000592	CcSEcCtD
Nelarabine—Fatigue—Prednisone—multiple sclerosis	1.98e-05	0.000591	CcSEcCtD
Nelarabine—Headache—Prednisolone—multiple sclerosis	1.98e-05	0.000591	CcSEcCtD
Nelarabine—Constipation—Prednisone—multiple sclerosis	1.96e-05	0.000586	CcSEcCtD
Nelarabine—ADA—Circadian rythm related genes—FAS—multiple sclerosis	1.95e-05	0.00784	CbGpPWpGaD
Nelarabine—Confusional state—Methotrexate—multiple sclerosis	1.94e-05	0.000578	CcSEcCtD
Nelarabine—Dizziness—Triamcinolone—multiple sclerosis	1.92e-05	0.000574	CcSEcCtD
Nelarabine—Dizziness—Methylprednisolone—multiple sclerosis	1.92e-05	0.000573	CcSEcCtD
Nelarabine—Infection—Methotrexate—multiple sclerosis	1.91e-05	0.000569	CcSEcCtD
Nelarabine—Feeling abnormal—Prednisone—multiple sclerosis	1.89e-05	0.000565	CcSEcCtD
Nelarabine—Asthenia—Dexamethasone—multiple sclerosis	1.89e-05	0.000565	CcSEcCtD
Nelarabine—Asthenia—Betamethasone—multiple sclerosis	1.89e-05	0.000565	CcSEcCtD
Nelarabine—Nervous system disorder—Methotrexate—multiple sclerosis	1.88e-05	0.000562	CcSEcCtD
Nelarabine—Thrombocytopenia—Methotrexate—multiple sclerosis	1.88e-05	0.000561	CcSEcCtD
Nelarabine—Gastrointestinal pain—Prednisone—multiple sclerosis	1.88e-05	0.000561	CcSEcCtD
Nelarabine—Nausea—Prednisolone—multiple sclerosis	1.88e-05	0.000561	CcSEcCtD
Nelarabine—ADA—Metabolism—SRM—multiple sclerosis	1.88e-05	0.00756	CbGpPWpGaD
Nelarabine—ADA—p73 transcription factor network—MYC—multiple sclerosis	1.87e-05	0.00754	CbGpPWpGaD
Nelarabine—Vomiting—Triamcinolone—multiple sclerosis	1.85e-05	0.000552	CcSEcCtD
Nelarabine—Vomiting—Methylprednisolone—multiple sclerosis	1.84e-05	0.000551	CcSEcCtD
Nelarabine—Anorexia—Methotrexate—multiple sclerosis	1.83e-05	0.000546	CcSEcCtD
Nelarabine—Headache—Triamcinolone—multiple sclerosis	1.82e-05	0.000544	CcSEcCtD
Nelarabine—Headache—Methylprednisolone—multiple sclerosis	1.82e-05	0.000542	CcSEcCtD
Nelarabine—Body temperature increased—Prednisone—multiple sclerosis	1.82e-05	0.000542	CcSEcCtD
Nelarabine—Abdominal pain—Prednisone—multiple sclerosis	1.82e-05	0.000542	CcSEcCtD
Nelarabine—Diarrhoea—Betamethasone—multiple sclerosis	1.8e-05	0.000539	CcSEcCtD
Nelarabine—Diarrhoea—Dexamethasone—multiple sclerosis	1.8e-05	0.000539	CcSEcCtD
Nelarabine—Hypotension—Methotrexate—multiple sclerosis	1.79e-05	0.000535	CcSEcCtD
Nelarabine—ADA—C-MYB transcription factor network—MYC—multiple sclerosis	1.78e-05	0.00718	CbGpPWpGaD
Nelarabine—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	1.75e-05	0.000522	CcSEcCtD
Nelarabine—Dizziness—Dexamethasone—multiple sclerosis	1.74e-05	0.000521	CcSEcCtD
Nelarabine—Dizziness—Betamethasone—multiple sclerosis	1.74e-05	0.000521	CcSEcCtD
Nelarabine—Insomnia—Methotrexate—multiple sclerosis	1.74e-05	0.000518	CcSEcCtD
Nelarabine—DGUOK—Metabolism—BCHE—multiple sclerosis	1.73e-05	0.00698	CbGpPWpGaD
Nelarabine—DCK—Metabolism—SRM—multiple sclerosis	1.73e-05	0.00697	CbGpPWpGaD
Nelarabine—Nausea—Triamcinolone—multiple sclerosis	1.73e-05	0.000515	CcSEcCtD
Nelarabine—Paraesthesia—Methotrexate—multiple sclerosis	1.72e-05	0.000515	CcSEcCtD
Nelarabine—Nausea—Methylprednisolone—multiple sclerosis	1.72e-05	0.000514	CcSEcCtD
Nelarabine—Dyspnoea—Methotrexate—multiple sclerosis	1.71e-05	0.000511	CcSEcCtD
Nelarabine—Somnolence—Methotrexate—multiple sclerosis	1.71e-05	0.000509	CcSEcCtD
Nelarabine—Vomiting—Betamethasone—multiple sclerosis	1.68e-05	0.000501	CcSEcCtD
Nelarabine—Vomiting—Dexamethasone—multiple sclerosis	1.68e-05	0.000501	CcSEcCtD
Nelarabine—Decreased appetite—Methotrexate—multiple sclerosis	1.67e-05	0.000498	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	1.66e-05	0.000495	CcSEcCtD
Nelarabine—Fatigue—Methotrexate—multiple sclerosis	1.65e-05	0.000494	CcSEcCtD
Nelarabine—Headache—Betamethasone—multiple sclerosis	1.65e-05	0.000493	CcSEcCtD
Nelarabine—Headache—Dexamethasone—multiple sclerosis	1.65e-05	0.000493	CcSEcCtD
Nelarabine—Asthenia—Prednisone—multiple sclerosis	1.65e-05	0.000492	CcSEcCtD
Nelarabine—Pain—Methotrexate—multiple sclerosis	1.64e-05	0.00049	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	1.6e-05	0.00645	CbGpPWpGaD
Nelarabine—DCK—Retinoblastoma (RB) in Cancer—MYC—multiple sclerosis	1.6e-05	0.00644	CbGpPWpGaD
Nelarabine—Feeling abnormal—Methotrexate—multiple sclerosis	1.58e-05	0.000472	CcSEcCtD
Nelarabine—Diarrhoea—Prednisone—multiple sclerosis	1.57e-05	0.000469	CcSEcCtD
Nelarabine—Gastrointestinal pain—Methotrexate—multiple sclerosis	1.57e-05	0.000469	CcSEcCtD
Nelarabine—Nausea—Dexamethasone—multiple sclerosis	1.57e-05	0.000468	CcSEcCtD
Nelarabine—Nausea—Betamethasone—multiple sclerosis	1.57e-05	0.000468	CcSEcCtD
Nelarabine—Dizziness—Prednisone—multiple sclerosis	1.52e-05	0.000453	CcSEcCtD
Nelarabine—Body temperature increased—Methotrexate—multiple sclerosis	1.52e-05	0.000453	CcSEcCtD
Nelarabine—Abdominal pain—Methotrexate—multiple sclerosis	1.52e-05	0.000453	CcSEcCtD
Nelarabine—Vomiting—Prednisone—multiple sclerosis	1.46e-05	0.000436	CcSEcCtD
Nelarabine—Headache—Prednisone—multiple sclerosis	1.44e-05	0.00043	CcSEcCtD
Nelarabine—Asthenia—Methotrexate—multiple sclerosis	1.38e-05	0.000411	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	1.37e-05	0.00552	CbGpPWpGaD
Nelarabine—Nausea—Prednisone—multiple sclerosis	1.36e-05	0.000407	CcSEcCtD
Nelarabine—POLA1—E2F transcription factor network—MYC—multiple sclerosis	1.35e-05	0.00543	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CYP24A1—multiple sclerosis	1.32e-05	0.00532	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CYP27B1—multiple sclerosis	1.32e-05	0.00532	CbGpPWpGaD
Nelarabine—Diarrhoea—Methotrexate—multiple sclerosis	1.31e-05	0.000392	CcSEcCtD
Nelarabine—Dizziness—Methotrexate—multiple sclerosis	1.27e-05	0.000379	CcSEcCtD
Nelarabine—Vomiting—Methotrexate—multiple sclerosis	1.22e-05	0.000364	CcSEcCtD
Nelarabine—DCK—Metabolism—CYP27B1—multiple sclerosis	1.22e-05	0.00491	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CYP24A1—multiple sclerosis	1.22e-05	0.00491	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GPC5—multiple sclerosis	1.21e-05	0.00487	CbGpPWpGaD
Nelarabine—Headache—Methotrexate—multiple sclerosis	1.2e-05	0.000359	CcSEcCtD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—MYC—multiple sclerosis	1.17e-05	0.00472	CbGpPWpGaD
Nelarabine—Nausea—Methotrexate—multiple sclerosis	1.14e-05	0.00034	CcSEcCtD
Nelarabine—DCK—Metabolism—GPC5—multiple sclerosis	1.12e-05	0.00449	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—APOE—multiple sclerosis	1.04e-05	0.0042	CbGpPWpGaD
Nelarabine—ADA—Metabolism—RRM1—multiple sclerosis	1e-05	0.00403	CbGpPWpGaD
Nelarabine—POLA1—G1/S Transition—MYC—multiple sclerosis	9.78e-06	0.00394	CbGpPWpGaD
Nelarabine—DCK—Metabolism—RRM1—multiple sclerosis	9.24e-06	0.00372	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—POMC—multiple sclerosis	8.95e-06	0.00361	CbGpPWpGaD
Nelarabine—POLA1—S Phase—MYC—multiple sclerosis	8.87e-06	0.00358	CbGpPWpGaD
Nelarabine—POLA1—Mitotic G1-G1/S phases—MYC—multiple sclerosis	8.24e-06	0.00332	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—ALB—multiple sclerosis	8.16e-06	0.00329	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—IL6—multiple sclerosis	6.67e-06	0.00269	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	6.24e-06	0.00251	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	6.23e-06	0.00251	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	6.11e-06	0.00246	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	5.81e-06	0.00234	CbGpPWpGaD
Nelarabine—ADA—Metabolism—BCHE—multiple sclerosis	5.75e-06	0.00232	CbGpPWpGaD
Nelarabine—DCK—Metabolism—BCHE—multiple sclerosis	5.31e-06	0.00214	CbGpPWpGaD
Nelarabine—POLA1—Mitotic M-M/G1 phases—MAPK1—multiple sclerosis	3.95e-06	0.00159	CbGpPWpGaD
Nelarabine—ADA—Metabolism—APOE—multiple sclerosis	3.46e-06	0.00139	CbGpPWpGaD
Nelarabine—DCK—Metabolism—APOE—multiple sclerosis	3.19e-06	0.00129	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—MYC—multiple sclerosis	3.02e-06	0.00122	CbGpPWpGaD
Nelarabine—ADA—Metabolism—POMC—multiple sclerosis	2.97e-06	0.0012	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—MAPK1—multiple sclerosis	2.96e-06	0.00119	CbGpPWpGaD
Nelarabine—DCK—Metabolism—POMC—multiple sclerosis	2.74e-06	0.00111	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ALB—multiple sclerosis	2.71e-06	0.00109	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—MYC—multiple sclerosis	2.7e-06	0.00109	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—MAPK1—multiple sclerosis	2.64e-06	0.00106	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ALB—multiple sclerosis	2.5e-06	0.00101	CbGpPWpGaD
